Report : South and Central America Neuromodulation Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Technology (External (Non-Invasive) Neuromodulation, and Internal Neuromodulation); Application (Chronic Pain Management, Failed Back Syndrome, Epilepsy, Tremor, Incontinence, Depression, Dystonia, Gastroparesis, Parkinson’s Disease, Obsessive-Compulsive Disorder, and Migraine); End User (Hospitals, Clinics, and Home Healthcare), and Country
Internal Neuromodulation Segment Held Largest Share of South & Central America Neuromodulation Market in 2019
According to a new market research study of ‘South & Central America Neuromodulation Market Forecast to 2027 - COVID-19 Impact and Analysis by Product Type, Material, Application, and Distribution Channel’ the South & Central America Neuromodulation market is expected to reach US$ 310.39 million in 2027 from US$ 221.74 million in 2019. The market is estimated to grow with a CAGR of 4.4% from 2020-2027.The report provides trends prevailing in the South & Central America Neuromodulation market and the factors driving market along with those that act as hindrances.
Based on the technology, the South & Central America Neuromodulation market is segmented into External (Non-Invasive) Neuromodulation and Internal Neuromodulation. The Internal Neuromodulation segment held the largest share of the market in 2019. The growth of the Internal Neuromodulation segment is attributed to the increasing product launches in the market, the rising product innovation for neuromodulation devices and growing developments in neuromodulation technology are also estimated to offer lucrative opportunity for the segment growth during the forecast period.
The growth of the market is attributed to the increasing incidence of neurological disorders, rapidly improving healthcare infrastructure, growing government support in the country. However, high Cost of Neuromodulation Devices is likely to restraint the growth of the market during the forecast years.
BOSTON SCIENTIFIC CORPORATION, ABBOTT and MEDTRONIC are among the leading companies operating in the South & Central America Neuromodulation market.
The report segments South & Central America Neuromodulation Market as Follows:
- External (Non-Invasive) Neuromodulation
- Respiratory Electrical Stimulation (RES)
- Transcutaneous Electrical Nerve Stimulation (TENS)
- Transcranial Magnetic Stimulation (TMS)
- Internal Neuromodulation
- Deep Brain Stimulation (DBS)
- Sacral Nerve Stimulation (SNS)
- Gastric Electrical Stimulation (GES)
- Spinal Cord Stimulation (SCS)
- Vagus Nerve Stimulation (VNS)
- Chronic Pain Management
- Failed Back Syndrome
- Parkinson’s Disease
- Obsessive-Compulsive Disorder
By End User
- Saudi Arabia
- South Africa
Contact Person: Sameer Joshi
Email Id: firstname.lastname@example.org